<DOC>
	<DOCNO>NCT02391090</DOCNO>
	<brief_summary>Stable Asthma patient ( GINA 1-2 ) stay 6 day row 4 hour per day hypoxic chamber simulate 2800m sea level . Study participant blind treatment give divide hypoxic sham group ( 360m sea level ) . Effects intermittent hypoxia asthmatic inflammation patient measure . The primary endpoint change force exhaled nitric oxide ( FeNO ) study . Secondary endpoint include blood parameter , lung function test questionnaire .</brief_summary>
	<brief_title>FeNO After Hypoxia Asthma Patients</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Anoxia</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>stable Asthma ( GINA 12 ) autoimmune disease unstable Asthma ( GINA 34 ) history pneumonia/fever within 3 month place residence &gt; 1000m sea level trip/vacation &gt; 2500m within 4 week cystic fibrosis diabetes mellitus immunodeficiency atopic dermatitis ciliary dyskinesia pregnancy chronic obstructive pulmonary disease history smoking ( &gt; 1py ) immunosuppression / systemic corticosteroid within 3 month cardiovascular disease interstitial lung disease bronchopulmonary dysplasia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>asthma</keyword>
	<keyword>hypoxia</keyword>
	<keyword>force exhale nitric oxide</keyword>
	<keyword>inflammation</keyword>
</DOC>